Lab21 Limited - Medical Equipment - Deals and Alliances Profile

Document Sample
Lab21 Limited - Medical Equipment - Deals and Alliances Profile Powered By Docstoc
					                              Lab21 Limited - Medical Equipment - Deals and Alliances Profile
       Reference Code: GDME173418D                                                                                                                Publication Date: MAR 2013

      Company Overview                                                                                          Key Facts
      Lab21 Limited (Lab21) is a personalized healthcare company. The company offers
                                                                                                                Lab21 Limited, Medical Equipment, Key Facts
      diagnostic products and services and supports medical diagnostics, blood bank
      screening and drug discovery. Lab21serves pharmaceutical and diagnostic firms                              Web Address                             www.lab-21.com
      and international healthcare providers. Lab21's diagnostic product division
                                                                                                                 Revenue (US$ million)                                NA
      manufactures immuno-diagnostic kits and reagents which is focused on infectious
      diseases for the blood banking and clinical markets. Its clinical services operations                      Number of Employees                                  NA
      provides high technology molecular assays and companion diagnostics.                                       GlobalData

      Financial Deals Landscape
        Lab21 Limited, Medical Equipment, Deals by Type, 2007 to YTD                       Lab21 Limited, Medical Equipment, Deals By Year, 2007 to
        2013                                                                               YTD 2013

                                                                                                           10
                                                                                                                                    8
                                                                                                           8




                                                                                            No. of Deals
                                                                                                                                                              6
                                                                                                           6

                                                                                                           4                                             3
                                                                                                                              2                                        2
                                                                                                           2        1
                                                                                                                                              0
                                                                                                           0
                                                                                                                  2007    2008    2009      2010     2011    2012     YTD
                                                                                                                                                                      2013


                                                                                           Note: Deals include all announced medical equipment deals from 2006
         Note: Deals include all announced medical equipment deals from 2006               onwards, GlobalData
         onwards, GlobalData


         Lab21 Limited, Medical Equipment, Deals By Region, 2007                           Lab21 Limited, Medical Equipment, Deals By Market, 2007
         to YTD 2013                                                                       to YTD 2013

                         25       20                                                                       25            22
          No. of Deals




                                                                                            No. of Deals




                         20                                                                                20
                         15                                                                                15
                         10                5                                                               10
                                                    4
                         5                                   2         2                                   5                            1            0            0
                         0                                                                                 0
                                Europe   North    Middle    Asia-    South                                           In Vitro     Specializ       Anesthes Cardiova
                                         Americ    East    Pacific    and                                           Diagnost        ed              ia and   scular
                                           a       and               Central                                            ics       Sectors         Respirat  Devices
                                                  Africa             Americ                                                                           ory
                                                                       a                                                                           Devices



         Note: Deals include all announced medical equipment deals from 2006               Note: Deals include all announced medical equipment deals from 2006
         onwards, GlobalData                                                               onwards, GlobalData


        Lab21 Limited, Medical Equipment, Deals Summary, 2007 to YTD 2013
        Year                                                      No. of Deals                                                              Deal Value (US$ million)
        2007                                                                                                             1                                                   NA
        2008                                                                                                             2                                                   3.27
        2009                                                                                                             8                                                   1.83
        2010                                                                                                            NA                                                    NA
        2011                                                                                                             3                                                    NA
        2012                                                                                                             6                                                   7.74
        YTD 2013                                                                                                         2                                                    NA
        Note: Deals include all announced medical equipment deals from 2006 onwards, deal values included wherever disclosed, GlobalData




Lab21 Limited - Medical Equipment - Deals and Alliances Profile                                                                                    Reference Code: GDME173418D
Source : www.globalcompanyintelligence.com                                                                                                                                     Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 4
       Lab21 Limited, Medical Equipment, Deals By Year, 2007 to YTD 2013............................................................................................. 5
       Lab21 Limited, Medical Equipment Deals By Type, 2007 to YTD 2013 ............................................................................................. 6
       Lab21 Limited, Medical Equipment, Deals By Region, 2007 to YTD 2013 ......................................................................................... 7
       Lab21 Limited, Medical Equipment, Deals By Market, 2007 to YTD 2013 ......................................................................................... 8
       Lab21 Limited, Medical Equipment, Deals Summary, 2007 to YTD 2013 .......................................................................................... 9
       Lab21 Limited, Medical Equipment, Deal Details ............................................................................................................................. 11
          Venture Financing......................................................................................................................................................................... 11
             Lab21 Raises $7.7 Million In Venture Financing ....................................................................................................................... 11
             Lab21 Secures $1.83 Million In Its Growth Capital Funding ...................................................................................................... 12
             Lab21 Secures $3.27 Million In Financing................................................................................................................................. 13
          Private Equity................................................................................................................................................................................ 14
             Selah Genomics Acquires Lab21, Maker Of Nanotechnology-Enabled Products ..................................................................... 14
          Partnerships.................................................................................................................................................................................. 15
             Lab21 Enters Into Licensing Agreement With Cooperative Diagnostics ................................................................................... 15
             Lab21 Enters Into An Agreement With deCODE genetics ........................................................................................................ 16
             Lab21 Enters Into Agreement With IntegraGen To Develop Cancer Diagnostic ....................................................................... 17
             BD Diagnostic Systems Enters Into Agreement With Lab21 To Develop New Oncology Assays ............................................. 18
             Lab21 Enters Into Co-Development Agreement With Pharma Company .................................................................................. 19
             LAB21 Enters Into Co-Development Agreement With IVD Company For Aspergillus Molecular Assay ................................... 20
             BD Diagnostics Enters Into Co-Development Agreement With Lab21 ...................................................................................... 21
             bioTheranostics Signs An Agreement With Lab21 .................................................................................................................... 22
             DiagnoCure Signs An Agreement With Lab21 .......................................................................................................................... 23
             Lab21 Enters Into Distribution Agreement With AdnaGen ........................................................................................................ 24
             Saladax Biomedical Signs Distribution Agreement With Lab21 ................................................................................................ 25
             Ark Therapeutics Signs A Licensing Agreement With Lab21 .................................................................................................... 26
          Asset Transactions ....................................................................................................................................................................... 27
             Lab21 Sells South Carolina Operations To Reedy Acquisitions ................................................................................................ 27
          Acquisition .................................................................................................................................................................................... 28
             Lab21 Acquires Myconostica .................................................................................................................................................... 28
             Lab21 Acquires Microgen Bioproducts ...................................................................................................................................... 29
             Lab21 Acquires Delphic Diagnostic From BDO......................................................................................................................... 30
             Lab21 Acquires Plasmatec Lab Products From Axis-Shield ..................................................................................................... 31
             LAB21 Acquires Biotec Labs ..................................................................................................................................................... 32
       Lab21 Limited - Key Competitors ..................................................................................................................................................... 33
       Key Employees ................................................................................................................................................................................ 34
       Locations And Subsidiaries .............................................................................................................................................................. 35
          Head Office ................................................................................................................................................................................... 35
          Other Locations & Subsidiaries ..................................................................................................................................................... 35
       Recent Developments ...................................................................................................................................................................... 36
          Strategy And Business Planning...........
				
DOCUMENT INFO
Description: Lab21 Limited (Lab21) is a personalized healthcare company. The company offers diagnostic products and services and supports medical diagnostics, blood bank screening and drug discovery. Lab21serves pharmaceutical and diagnostic firms and international healthcare providers. Lab21's diagnostic product division manufactures immuno-diagnostic kits and reagents which is focused on infectious diseases for the blood banking and clinical markets. Its clinical services operations provides high technology molecular assays and companion diagnostics. Lab21 has office in South Carolina, the US and Cambridge, the UK with a GMP manufacturing facility in Cambridge and other manufacturing sites in Camberley, Bridport and Newmarket. The company is headquartered in Cambridge, the UK.
BUY THIS DOCUMENT NOW PRICE: $250 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.